Submacular combination treatment for management of acute, massive submacular hemorrhage in age-related macular degeneration

Ophthalmic Surgery Lasers and Imaging

Volumn 40, Issue 3, 2009, Pages 308-315

  Shah, Sumit P ^a   Hubschman, Jean Pierre ^a   Gonzales, Christine R ^a   Schwartz, Steven D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN ANTIBODY;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; VISUAL ACUITY; VITRECTOMY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; APTAMERS, NUCLEOTIDE; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR DEGENERATION; MALE; RECOMBINANT PROTEINS; RETINAL HEMORRHAGE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY;

EID: 67149146286     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20090430-16     Document Type: Article

References (28)

1. Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol. 1997;42:195-213.
2. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol. 1996;122:486-493. Erratum in: Am J Ophthalmol. 1996;122:920.
3. Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol. 1990;109:33-37. (Pubitemid 20026485)
4. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16:183-189. (Pubitemid 26190846)
5. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica. 1999;213:97-102. (Pubitemid 29049394)
6. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94:762-773. (Pubitemid 13203669)
7. Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol. 1998;116:1326-1332. (Pubitemid 28473837)
8. Daneshvar H, Kertes PJ, Leonard BC, Peyman GA. Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study. Can J Ophthalmol. 1999;34:385-388.
9. Schulze SD, Hesse L. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome. Graefes Arch Clin Exp Ophthalmol. 2002;240:717-720. (Pubitemid 36097098)
10. Hattenbach LO, Klais C, Koch FH, Gümbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology. 2001;10:1485-1492. (Pubitemid 32709042)
11. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999;106:1900-1906.
12. Chen CY, Hooper CY, Chiu D, Chamberlain M, Karia N, Heriot WJ. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina. 2007;27:321-328. (Pubitemid 46398897)
13. Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement. Arch Ophthalmol, 2001;119:28-32. (Pubitemid 32096382)
14. Krepler K, Kruger TA, Tittl M, Stur M, Wedrich A. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration. Retina. 2000;20:251-256. (Pubitemid 30436776)
15. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol. 1999;237:273-277. (Pubitemid 29145803)
16. Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol. 1996;121:267-275. (Pubitemid 26085090)
17. Thompson JT, Sjaarda RN. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement. Trans Am Ophthalmol Soc. 2005;103:98-107. (Pubitemid 43042116)
18. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology. 2004;111:1201-1208. Erratum in: Ophthalmology. 2004;111:1640. (Pubitemid 38737001)
19. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol. 1994;118:559-568. (Pubitemid 24345617)
20. Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage: a series of 47 consecutive cases. Arch Ophthalmol. 1995;113:62-69.
21. Haupert CL, McCuen BW 2nd, Jaffe GJ, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol. 2001;131:208-215. (Pubitemid 32157035)
22. Moriarty AP, McAllister IL, Constable IJ. Initial clinical experience with tissue plasminogen activator (tPA) assisted removal of submacular haemorrhage. Eye. 1995;9:582-588.
23. Lim JI, Drews-Botsch C, Sternberg P Jr, Capone A Jr, Aaberg TM Sr. Submacular hemorrhage removal. Ophthalmology. 1995;102:1393-1399.
24. Saika S, Yamanaka A, Yamanaka A, et al. Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhage. Graefes Arch Clin Exp Ophthalmol. 1998;236:196-201. (Pubitemid 28083233)
25. Lewis H, Resnick SC, Flannery JG, Straatsma BR. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol. 1991;111:197-204.
26. Dong LM, Childs AL, Mangione CM, et al. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST Report No. 4. Am J Ophthalmol. 2004;138:91-108. (Pubitemid 38850254)
27. Dafer RM, Schneck M, Friberg TR, Jay WM. Intravitreal ranibizumab and bevacizumab: a review of risk. Semin Ophthalmol. 2007;22:201-204. (Pubitemid 47346972)
28. Chang LK, Sarraf D. Tears of the retinal pigment epithelium: an old problem in a new era. Retina. 2007;27:523-534. (Pubitemid 46905141)